Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio 45267, USA.
J Pharm Sci. 2013 Feb;102(2):480-8. doi: 10.1002/jps.23370. Epub 2012 Nov 13.
Mixed micelles prepared using sodium taurocholate (TA) and egg lecithin (LE) were previously found to be an effective carrier for sustained release of a poorly water-soluble drug in transscleral iontophoretic delivery. The objectives of the present study were to investigate the effects of drug lipophilicity upon micellar carrier solubilization potential and drug release profiles from the sclera after iontophoretic delivery of model lipophilic drugs dexamethasone (DEX), triamcinolone acetonide (TRIAM), and β-estradiol (E2β) with a mixed micellar carrier system of TA-LE (1:1 mole ratio). In this study, the micellar carrier system was characterized for drug solubilization. The micelles encapsulating these drugs were evaluated for transscleral passive and 2-mA iontophoretic delivery (both cathodal and anodal) and drug release from excised human sclera in vitro. The results show that drug solubility enhancement of the micellar carrier system increased with increasing drug lipophilicity. The more lipophilic drugs E2β and TRIAM displayed slower drug release from the sclera compared with the less lipophilic drug DEX after iontophoretic drug delivery with the mixed micelles. These results suggest that the combination of transscleral iontophoresis and micellar carriers is more effective in sustaining transscleral delivery of the more lipophilic drugs studied in this investigation.
先前的研究发现,使用牛磺胆酸钠(TA)和卵磷酯(LE)制备的混合胶束是一种有效的载体,可用于在经巩膜离子导入递药时持续释放亲脂性差的药物。本研究的目的是考察药物脂溶性对胶束载体增溶潜力的影响,以及在用 TA-LE(1:1 摩尔比)混合胶束载体系统经巩膜离子导入递药后,模型亲脂性药物地塞米松(DEX)、曲安奈德(TRIAM)和雌二醇(E2β)从巩膜中释放的药物释放特征。在本研究中,对胶束载体系统进行了药物增溶能力的特征描述。对包封这些药物的胶束进行了评估,以考察其经巩膜被动和 2-mA 离子导入(阴极和阳极)递药以及在离体人巩膜中的药物释放能力。结果表明,胶束载体系统的药物增溶能力随药物脂溶性的增加而提高。与脂溶性较低的药物 DEX 相比,经巩膜离子导入药物递送后,脂溶性更高的药物 E2β 和 TRIAM 从巩膜中的药物释放速度更慢。这些结果表明,联合使用经巩膜离子导入和胶束载体系统更有利于持续递药,这对本研究中考察的更亲脂性药物具有重要意义。